NCT05390411Enrolling by invitation
Seeking Objectivity in Allocation of Advanced Heart Failure (SOCIAL HF) Therapies Trial
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
The primary goal of this study is to assess real-world effectiveness and implementation of an evidence-based multi-component strategy to reduce disparities in the allocation rate of advanced heart failure therapies, heart transplants and ventricular assist devices. This study proposes to implement evidence-based strategies that reduce unequal and unethical decision-making towards patients, replace subjective evaluations with objective criteria, and improve group dynamics in a randomized cluster trial. Our rigorously designed trial will inform national guidelines for advanced heart failure therapy allocation, and data are likely to be generalizable to other organ replacement treatments and advanced chronic disease decision-making processes across populations.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 1463 (estimated)
- First submitted
- 21 Mar 2022
- Start date
- 6 Mar 2023
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Indiana University
- Diseases
- Heart failure
- NCT number
- NCT05390411
What you commit to
- Study type: Interventional
- Planned participants: 1463
- From 6 Mar 2023 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- If the center ceases to be an active heart failure/transplant center
Other
- Centers unable to fully participate in the training and evaluation measures
Who the study is looking for
- Active United Network for Organ Sharing heart transplant and ventricular assist device center
- Centers that routinely evaluate at least 50 minoritized racial/ethnic patients and 50 women for advanced heart failure therapies (heart transplant and ventricular assist device) over 2 years
- Advanced therapy professionals from participating centers (i.e., coordinators, physicians, pharmacists, nurses, social workers)
- Participants for the interview portion will be a subset of otherwise eligible advanced therapy professionals who are included on selection meeting attendance sheets at an included center
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Indiana University Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.